Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2025, 34(2):84-92

Risk profile of anatomical and functional parameters of patent foramen ovale and associated anatomical structures in patients with cryptogenic stroke or transient ischemic attack

Juraj Dúbrava1, Rastislav Šidlo2
1 Department of Noninvasive Cardiology, University Hospital Bratislava, Slovakia
2 Faculty of Economic Informatics, University of Economics, Bratislava, Slovakia

Background: This study evaluated the risk profile of patent foramen ovale (PFO) parameters and associated structures for cryptogenic cerebrovascular (CV) accidents.

Methods: We enrolled prospectively 1270 consecutive patients who underwent contrast transesophageal echocardiography: 702 patients with cryptogenic stroke (CS) or transient ischemic attack (TIA) and 568 controls without CV accidents. In this study, we evaluated the patients diagnosed with PFO. We compared 224 patients with CS or TIA and PFO (31.9%) to 106 controls with the incidental finding of a PFO (18.7%). Diameter and length of the PFO, large PFO (diameter ≥ 4 mm), long PFO (length ≥ 10 mm), shunt presence without Valsalva maneuver, shunt severity, atrial septal aneurysm (ASA; septal excursion ≥ 15 mm), atrial septal defect, and Eustachian valve/Chiari network were assessed.

Results: All characteristics of PFO significantly increased relative risk (RR) of CS/TIA vs population without PFO [RR (95%CI)] - PFO: 2.04 (1.57;2.66); p<0.001, large PFO: 4.99 (2.66;9.39); p<0.001, PFO with diameter ≥ median 2.4 mm: 3.20 (2.19;4.68); p<0.001, long PFO: 2.25 (1.65;3.06); p<0.001, PFO with length ≥ median 12 mm: 2.26 (1.61;3.17); p<0.001, moderate or large shunt: 2.25 (1.65;3.08); p<0.001, shunt present without Valsalva maneuver: 2.47 (1.74;3.52); p<0.001. PFO diameter ≥ median 2.4 mm and long PFO were identified in a multivariate logistic regression analysis as significant risk factors of CS/TIA - 2.43 (1.58;3.74) ;p<0.001 and 1.46 (1.02; 2.08); p<0.05, respectively. In contrast, ASA, PFO+ASA, atrial septal defect, Eustachian valve/Chiari network each did not increase the risk of CV accidents vs population without respective structure.

Conclusions: Out of the PFO parameters a large diameter most significantly increased the risk of CS/TIA. Long PFO, shunt presence without Valsalva maneuver and moderate/large shunt also significantly increased the risk. The atrial septal or right atrial structures potentially associated with PFO did not increase the risk.

Keywords: patent foramen ovale; cryptogenic stroke; transesophageal echocardiography atrial septal aneurysm

Published: February 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dúbrava J, Šidlo R. Risk profile of anatomical and functional parameters of patent foramen ovale and associated anatomical structures in patients with cryptogenic stroke or transient ischemic attack. Cardiology Letters. 2025;34(2):84-92.
Download citation

References

  1. Pristipino C, Sievert H, D'Ascenzo F, Louis Mas J, Meier B, Scacciatella P, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 2019;40:3182-3195. Go to original source...
  2. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 2009;103:124-129. Go to original source...
  3. Bayar N, Arslan Ş, Çağirci G, Erkal Z, Üreyen ÇM, Çay S, et al. Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients. J Stroke Cerebrovasc Dis 2015;24:1282-1286. Go to original source...
  4. Natanzon A, Goldman ME. Patent foramen ovale: anatomy versus pathophysiology - which determines stroke risk? J Am Soc Echocardiogr 2003;16:71-76. Go to original source...
  5. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-462. Go to original source...
  6. Cerrato P, Imperiale D, Priano L, Mangiardi L, Morello M, Marson AM, et al. Transoesophageal echocardiography in patients without arterial and major cardiac sources of embolism: difference between stroke subtypes. Cerebrovasc Dis 2002;13:174-183. Go to original source...
  7. Mesa D, Franco M, Suárez de Lezo J, Muñoz J, Rus C, Delgado M, et al. Prevalence of patent foramen ovale in young patients with cerebral ischemic accident of unknown origin. Rev Esp Cardiol 2003;56:662-668. Go to original source...
  8. Komar M, Podolec P, Przewłocki T, Wilkołek P, Tomkiewicz-Pająk L, Motyl R. Transoesophageal echocardiography can help distinguish between patients with "symptomatic" and "asymptomatic" patent foramen ovale. Kardiol Pol 2012;70:1258-1263.
  9. Nakayama R, Takaya Y, Akagi T, Watanabe N, Ikeda M, Nakagawa K, et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr 2019;32:811-816. Go to original source...
  10. Hołda MK, Koziej M. Morphometric Features of Patent Foramen Ovale as a Risk Factor of Cerebrovascular Accidents: A Systematic Review and Meta-Analysis. Cerebrovasc Dis 2020;49:1-9. Go to original source...
  11. Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med 2017;377:10111021. Go to original source...
  12. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 2017;377:1022-1032. Go to original source...
  13. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746. Go to original source...
  14. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623. Go to original source...
  15. Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, Hagler DJ, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985;6:1370-1382. Go to original source...
  16. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357:2262-2268. Go to original source...
  17. Lee JY, Song JK, Song JM, Kang DH, Yun SC, Kang DW, et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 2010;106:129-134. Go to original source...
  18. Katsanos AH, Spence JD, Bogiatzi C, Parissis J, Giannopoulos S, Frogoudaki A, et al. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis. Stroke 2014;45:3352-3359. Go to original source...
  19. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413. Go to original source...
  20. Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative highrisk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging 2014;7:125-131. Go to original source...
  21. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 2002;33:293-296. Go to original source...
  22. Kumar P, Rusheen J, Tobis JM. A comparison of methods to determine patent foramen ovale size. Catheter Cardiovasc Interv 2020;96:E621-E629. Go to original source...
  23. Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, et al. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J 2018;39:1638-1649. Go to original source...
  24. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J Am Coll Cardiol 2018;71:2335-2342. Go to original source...
  25. Hołda MK, Koziej M, Hołda J, Piątek K, Tyrak K, Chołopiak W, et al. Atrial Septal Pouch-Morphological Features and Clinical Considerations. Int J Cardiol 2016;220:337-342. Go to original source...
  26. Tanaka J, Izumo M, Fukuoka Y, Saitoh T, Harada K, Harada K, et al. Comparison of two-dimensional versus real-time three-dimensional transesophageal echocardiography for evaluation of patent foramen ovale morphology. Am J Cardiol 2013;111:1052-1056. Go to original source...